Aids Malignancy Consortium
Clinical trials sponsored by Aids Malignancy Consortium, explained in plain language.
-
Experimental drug aims to shrink kaposi sarcoma lesions
Disease control Not yet recruitingThis study tests a drug called nirogacestat in 28 people with Kaposi sarcoma (KS) that affects the skin. The drug blocks a protein that helps cancer cells grow, with the goal of shrinking tumors and preventing new ones. While current treatments can help, there is no cure for KS, …
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Could a common heart drug shrink kaposi sarcoma tumors?
Disease control Not yet recruitingThis study tests whether propranolol, a drug usually used for high blood pressure, can treat Kaposi sarcoma. About 25 children and adults with measurable tumors will receive the drug and be monitored for tumor shrinkage and side effects. The goal is to see if this safer, more acc…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New study tests cheaper chemo options for HIV cancer in africa
Disease control Not yet recruitingThis study compares two chemotherapy drugs, paclitaxel and pegylated liposomal doxorubicin, to see if they work similarly well for treating Kaposi sarcoma in people with HIV. The trial will enroll 130 participants in sub-Saharan Africa, giving each drug once every three weeks for…
Phase: PHASE3 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated May 11, 2026 20:53 UTC